Excerpt from the Blog: "The Quest for Safer, More Targeted Therapies for Patients".

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Abstract:
      An excerpt from the article "The Quest for Safer, More Targeted Therapies" by Fraser McLeod, Vice President of QA/QC at Waters, discusses how Waters' acquisition of Wyatt Technology aims to accelerate the development of biological, cell, and gene therapies by integrating innovative technologies.